Insights

Innovative Licensing PharmaCielo holds the distinction of being the first company in Colombia with licenses for unrestricted THC and CBD percentages, positioning it as a leader in the premium medicinal cannabis market and offering unique product development opportunities.

Global Supply Chain With operations based in both Canada and Colombia, PharmaCielo combines strategic geographic advantages and extensive cultivation capacity, enabling it to serve international clients seeking reliable and high-quality medicinal cannabis extracts.

Targeted B2B Model The company's emphasis on B2B sales to large distributors, manufacturers, and pharmaceutical organizations creates multiple touchpoints for sales expansion and partnership development within the medical cannabis industry.

Strong Industry Positioning As the largest licensed cannabis producer globally with a focus on standardized medicinal-grade oils, PharmaCielo presents opportunities for sales of processing equipment, cultivation technologies, and proprietary extraction solutions.

Growth Potential With recent funding and a revenue range of up to $10 million, PharmaCielo is positioned for expansion into new markets and product lines, offering potential sales opportunities in ancillary services, technology, and supply chain enhancements.

Similar companies to PharmaCielo

PharmaCielo Tech Stack

PharmaCielo uses 8 technology products and services including Amazon Web Services, RSS, Mura CMS, and more. Explore PharmaCielo's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • RSS
    Content Management System
  • Mura CMS
    Content Management System
  • Microsoft 365
    Email
  • jQuery UI
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • Slider Revolution
    Miscellaneous
  • Adobe ColdFusion
    Web Frameworks

Media & News

PharmaCielo's Email Address Formats

PharmaCielo uses at least 1 format(s):
PharmaCielo Email FormatsExamplePercentage
F.Last@pharmacielo.comJ.Doe@pharmacielo.com
48%
FirstLast@pharmacielo.comJohnDoe@pharmacielo.com
2%
FirLast@pharmacielo.comJohDoe@pharmacielo.com
2%
F.Last@pharmacielo.comJ.Doe@pharmacielo.com
48%

Frequently Asked Questions

Where is PharmaCielo's headquarters located?

Minus sign iconPlus sign icon
PharmaCielo's main headquarters is located at Toronto, ON M5V 3B6 CA. The company has employees across 3 continents, including South AmericaNorth AmericaEurope.

What is PharmaCielo's stock symbol?

Minus sign iconPlus sign icon
PharmaCielo is a publicly traded company; the company's stock symbol is PCLO.V.

What is PharmaCielo's official website and social media links?

Minus sign iconPlus sign icon
PharmaCielo's official website is pharmacielo.com and has social profiles on LinkedInCrunchbase.

What is PharmaCielo's NAICS code?

Minus sign iconPlus sign icon
PharmaCielo's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does PharmaCielo have currently?

Minus sign iconPlus sign icon
As of October 2025, PharmaCielo has approximately 106 employees across 3 continents, including South AmericaNorth AmericaEurope. Key team members include Chief Financial Officer: I. A.Head Of Operations Planning: P. C.President, Global Head Health & Innovation: D. H.. Explore PharmaCielo's employee directory with LeadIQ.

What industry does PharmaCielo belong to?

Minus sign iconPlus sign icon
PharmaCielo operates in the Pharmaceutical Manufacturing industry.

What technology does PharmaCielo use?

Minus sign iconPlus sign icon
PharmaCielo's tech stack includes Amazon Web ServicesRSSMura CMSMicrosoft 365jQuery UIOWL CarouselSlider RevolutionAdobe ColdFusion.

What is PharmaCielo's email format?

Minus sign iconPlus sign icon
PharmaCielo's email format typically follows the pattern of F.Last@pharmacielo.com. Find more PharmaCielo email formats with LeadIQ.

How much funding has PharmaCielo raised to date?

Minus sign iconPlus sign icon
As of October 2025, PharmaCielo has raised $3.5M in funding. The last funding round occurred on May 11, 2022 for $3.5M.

When was PharmaCielo founded?

Minus sign iconPlus sign icon
PharmaCielo was founded in 2014.
PharmaCielo

PharmaCielo

Pharmaceutical ManufacturingOntario, Canada51-200 Employees

Nature’s choice from Colombia. 

PharmaCielo Ltd. is the world’s largest licensed cannabis producer. We’re the first company to hold Colombian licences for unrestricted percentages of tetrahydrocannabinol (THC) and cannabidiol (CBD).

Our mission is to become the world’s leading supplier of naturally grown and processed, standardized medicinal-grade cannabis oil extracts and related products. PharmaCielo employs a B2B sales and distribution model targeting large channel distributors, finished goods manufacturers, research organizations and pharmaceutical companies.

PharmaCielo Ltd. is a global company headquartered in Ontario, Canada, chosen for the country’s standards of financial accountability and regulatory oversight.

PharmaCielo Colombia Holdings S.A.S., its wholly owned operating subsidiary, is headquartered in Rionegro, Colombia – a country with outstanding economic conditions, a clear legal framework for cannabis licensing and ideal climatic conditions. The company’s facility, combined with its contract growers’ space, offers access to 110.2 million square feet of open-air greenhouse cultivation capacity. 

The combination of the two countries – Canada and Colombia – is a winning structure for developing a sustainable international business model capable of capturing a significant share of the rapidly growing medical cannabis industry.

Section iconCompany Overview

Headquarters
Toronto, ON M5V 3B6 CA
Stock Symbol
PCLO.V
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2014
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $3.5M

    PharmaCielo has raised a total of $3.5M of funding over 6 rounds. Their latest funding round was raised on May 11, 2022 in the amount of $3.5M.

  • $1M$10M

    PharmaCielo's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $3.5M

    PharmaCielo has raised a total of $3.5M of funding over 6 rounds. Their latest funding round was raised on May 11, 2022 in the amount of $3.5M.

  • $1M$10M

    PharmaCielo's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.